HUMAN CLOTTABLE PROTEIN/HUMAN THROMBIN Adverse Event: Embolism arterial
HUMAN CLOTTABLE PROTEIN/HUMAN THROMBIN Adverse Event: Embolism arterial is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: HUMAN CLOTTABLE PROTEIN/HUMAN THROMBIN; Product category: Drug; Primary reaction: Embolism arterial.
| Primary drug | HUMAN CLOTTABLE PROTEIN/HUMAN THROMBIN |
|---|---|
| Product category | Drug |
| Primary reaction | Embolism arterial |
| All reactions | Embolism arterial; Pulmonary embolism; Phlebitis |
| Seriousness | Serious |
| Patient outcome | Recovered/Resolved |
| Patient sex | Unknown |
| All drugs reported | HUMAN CLOTTABLE PROTEIN/HUMAN THROMBIN |
| Reporter country | FR |
| Reporter type | 1 |
| Report date | 20140312 |
| Report ID | 10004233 |
$299/mo
Try FDATracker →